JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 4 1:08 PM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 33,597 | $274.74 | $9.2M | 25,447(D) | View → |
| Sep 2, 2026 | Sep 2 3:26 PM | Schmid Timothy | Proposed Sale | 33,597 | $274.74 | $9.2M | — | View → |
| Aug 17, 2026 | Aug 18 10:31 PM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Sale | 15,000 | $263.36 | $4.0M | 194,451.001(D) | View → |
| Aug 17, 2026 | Aug 17 4:51 PM | Taubert Jennifer L | Proposed Sale | 15,000 | $263.36 | $4.0M | — | View → |
| Aug 13, 2026 | Aug 14 8:35 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 123,291 | $261.17 | $32.2M | 275,967(D) | View → |
| Aug 13, 2026 | Aug 13 6:12 PM | Duato Joaquin | Proposed Sale | 123,291 | $261.17 | $32.2M | — | View → |
| Aug 5, 2026 | Aug 7 9:50 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 48,480 | $258.15 | $12.5M | 275,967(D) | View → |
| Aug 6, 2026 | Aug 7 9:44 PM | Elizabeth ForminardEVP, Chief Legal Officer | Sale | 15,918 | $257.00 | $4.1M | 16,994(D) | View → |
| Aug 6, 2026 | Aug 6 6:02 PM | Forminard Elizabeth | Proposed Sale | 15,918 | $257.00 | $4.1M | — | View → |
| Aug 5, 2026 | Aug 5 10:07 PM | Joaquin Duato | Proposed Sale | 48,480 | $254.93 | $12.4M | — | View → |
| Jul 20, 2026 | Jul 21 9:27 PM | Vanessa BroadhurstEVP, Global Corp Affairs | Sale | 23,054 | $251.27 | $5.8M | 23,003(D) | View → |
| Jul 20, 2026 | Jul 20 5:35 PM | Broadhurst Vanessa | Proposed Sale | 23,054 | $251.27 | $5.8M | — | View → |
| Jun 11, 2026 | Jun 12 9:23 PM | Kathryn E WengelEVP, Chief TO and Risk Officer | Sale | 10,000 | $241.15 | $2.4M | 114,287.874(D) | View → |
| Jun 11, 2026 | Jun 11 5:44 PM | Wengel Kathryn E | Proposed Sale | 10,000 | $240.15 | $2.4M | — | View → |
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Sale | 4,075 | $247.87 | $1.0M | 23,682(D) | View → |
| Feb 27, 2026 | Feb 27 7:35 PM | Decker Robert J | Proposed Sale | 4,075 | $247.87 | $1.0M | — | View → |
| Feb 20, 2026 | Feb 23 10:20 PM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 1,322 | $245.66 | $324.8K | 25,447(D) | View → |
| Feb 20, 2026 | Feb 20 3:46 PM | Schmid Timothy | Proposed Sale | 1,322 | $245.66 | $324.8K | — | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Sale | 20,521 | $242.70 | $5.0M | 25,698.131(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Sale | 41,559 | $243.73 | $10.1M | 25,020.131(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 11 12:51 AM | Daniel E PintoDirector | Grant/Award | 113.098 | — | 2,445.177(D) | View → |
| Sep 8, 2026 | Sep 11 12:50 AM | Eugene A. WoodsDirector | Grant/Award | 135.717 | — | 6,578.771(D) | View → |
| Sep 8, 2026 | Sep 11 12:50 AM | Marillyn A HewsonDirector | Grant/Award | 180.956 | — | 16,049.417(D) | View → |
| Sep 2, 2026 | Sep 4 1:08 PM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 33,597 | $151.41 | 0(D) | View → |
| Aug 17, 2026 | Aug 18 10:31 PM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Option Exercise | 15,000 | $115.67 | 28,712(D) | View → |
| Aug 13, 2026 | Aug 14 8:35 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Option Exercise | 123,291 | $115.67 | 0(D) | View → |
| Aug 6, 2026 | Aug 7 9:44 PM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 9,344 | $131.94 | 0(D) | View → |
| Jul 20, 2026 | Jul 21 9:27 PM | Vanessa BroadhurstEVP, Global Corp Affairs | Option Exercise | 23,054 | $131.94 | 0(D) | View → |
| Jun 11, 2026 | Jun 12 9:23 PM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 10,000 | $115.67 | 32,965(D) | View → |
| Jun 9, 2026 | Jun 11 8:56 PM | Eugene A. WoodsDirector | Grant/Award | 161.089 | — | 6,411.959(D) | View → |
| Jun 9, 2026 | Jun 11 8:43 PM | Daniel E PintoDirector | Grant/Award | 134.241 | — | 2,320.824(D) | View → |
| Jun 9, 2026 | Jun 11 8:35 PM | Marillyn A HewsonDirector | Grant/Award | 214.786 | — | 15,791.877(D) | View → |
| May 1, 2026 | May 4 8:58 PM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 25,255 | — | 0(D) | View → |
| Apr 23, 2026 | Apr 27 10:23 PM | Eugene A. WoodsDirector | Grant/Award | 975 | — | 6,215.094(D) | View → |
| Apr 23, 2026 | Apr 27 10:21 PM | Nadja WestDirector | Grant/Award | 975 | — | 7,730.049(D) | View → |
| Apr 23, 2026 | Apr 27 10:17 PM | Mark A WeinbergerDirector | Grant/Award | 975 | — | 12,010.408(D) | View → |
| Apr 23, 2026 | Apr 27 10:13 PM | Daniel E PintoDirector | Grant/Award | 1,712 | — | 2,174.069(D) | View → |
| Apr 23, 2026 | Apr 27 10:12 PM | John G MorikisDirector | Grant/Award | 1,540 | — | 1,540(D) | View → |
| Apr 23, 2026 | Apr 27 10:06 PM | Mark B. McclellanDirector | Grant/Award | 975 | — | 21,278.593(D) | View → |
| Apr 23, 2026 | Apr 27 10:05 PM | Hubert JolyDirector | Grant/Award | 975 | — | 9,183.605(D) | View → |
Page 1 of 4
Next →